World Health Statistics 2023: monitoring health for the SDGs
Global Health NewsHealth in DataPublic Health InformationPublic Health NewsPublic Health UpdateReportsSustainable Development Goals (SDGs)

World Health Statistics 2023: monitoring health for the SDGs

by Public Health Update
written by Public Health Update

World Health Statistics report

The World Health Statistics 2023 report is the World Health Organization’s (WHO) annual compilation of the latest available data on health and health-related indicators. Published since 2005. The report summarises the trends in life expectancy and causes of death, and reports on progress towards the health-related Sustainable Development Goals (SDGs) and associated targets.

WHO is releasing the 2023 edition of its annual World Health Statistics report with new figures on the impact of COVID-19 pandemic and the latest statistics on progress towards the health-related Sustainable Development Goals (SDGs).

The report with data up to 2022 underscores a stagnation of health progress on key health indicators in recent years compared with trends seen during 2000-2015. It also alerts us to the growing threat of noncommunicable diseases (NCDs) and climate change, and calls for a coordinated and strengthened response.

Key Statistics

  • Between 2000 and 2020, the global number of maternal deaths fell from 447 000 to 287 000 and the global maternal mortality ratio decreased from 339 deaths per 100 000 live births to 223 deaths per 100 000 live births.
  • The global under-five mortality rate reduced by half between 2000 and 2021, from 76 deaths per 1000 live births to 38 deaths per 1000 live births.
  • The global neonatal mortality rate – infant deaths within the first month of life – improved from 31 deaths per 1000 live births (2000) to 18 deaths per 1000 live births (2021).
  • Between 2000 and 2019, the number of deaths caused by NCDs increased by more than one third, from 31 million lives lost to 41 million lives lost – almost 3 of every four deaths worldwide. Similarly, in 2000, NCDs caused 47% of global disability-adjusted life years (1.3 billion years); by 2019, NCDs caused 63% (1.6 billion years).
  • The four major NCDs, namely cardiovascular disease (17.9 million deaths), cancer (9.3 million deaths), chronic respiratory disease (4.1 million deaths) and diabetes (2.0 million deaths), collectively killed about 33.3 million people in 2019, a 28% increase compared to 2000.
  • The average life expectancy of a human born in 1950 was just 46.5 years. But by 2019, it had increased to 73 years.
  • In 2000, 61% of global deaths were due to NCDs. Another 31% were deaths from communicable, maternal, perinatal and nutritional conditions (which we’ll refer to as the communicable group). By 2019, global deaths from NCDs had increased to 74%, while the communicable group had fallen to 18%. Deaths attributed to injuries remained roughly constant at around 8%.
  • Years of Life Lost (YLL) estimates show that a total of 336.8 million life-years have been lost globally due to COVID-19. And YLL is the highest globally in ages 55-64 years old, with a total of over 90 million years of life lost.

DOWNLOAD FULL REPORT (WHO)

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Government Policies and Programmes for the Fiscal Year 2080/081(2023-24)
Health Financing and EconomicsNational Health NewsNational Plan, Policy & GuidelinesPublic HealthPublic Health Update

Government Policies and Programmes for the Fiscal Year 2080/081(2023-24)

by Public Health Update
written by Public Health Update

The Government of Nepal has presented the policies and programmes for the upcoming fiscal year 2080/081 (2023-24) at the joint meeting of the House of Representatives and National Assembly. Here are the major policies and programmes related to health.

  • Citizens’ access to communication and information technology will be increased. Use of information technology will be expanded in education, health, development activities, and service delivery. Research, development and extension of information technology system will be carried out for knowledge based economy and good governance.
  • A National Integrated Emergency Service System will be established and brought into operation with the integrated mobilization of ambulances, fire engines, security personnel and health workers for the immediate rescue and treatment of people severely injured by fire, accidents and criminal activities.
  • Gender equality and women empowerment policy will be implemented effectively. Leadership development of women will be emphasized while ensuring their meaningful participation and representation at policy making level. Women-focused programs on education, health, employment, poverty alleviation, livelihood improvement, social security and access to infrastructure will be conducted.
  • The lives of senior citizens will be made dignified, secure and orderly. Their knowledge, skills and experience will be utilized for the prosperity of the nation. They will be provided discounts and concessions on health related and other services. Well-equipped Senior Citizen Homes, Services and Friendship Centers, and Health Centers will be constructed in various provinces and municipalities in coordination of the provincial and local levels. The hospitals providing health services to senior citizens will be further strengthened.
  • Access to quality health services for all citizens will be ensured. The health insurance program will be reviewed. National and state-level telemedicine centers will continue to be established as centers for excellence at provincial level. A health center with basic health examination and treatment will be established in each ward. Basic health services will be provided to disabled, helpless and senior citizens at their doorstep.
  • To provide basic health services, arrangements will be made to provide one MDGP, one Gynecologist and Obstetrician, at least three medical officers and necessary nurses, technical manpower including lab, equipment and material required for laboratory, diagnostic equipment including X-ray, ultrasound, echo ECG, ambulance with oxygen facility in basic hospitals. Doctors working in basic hospitals will be given the opportunity to study in higher medical education.
  • Arrangements will be made for mandatory operation of OPD services from 8.00 am to 8.00 pm while ensuring at least one hospital, one doctor in all community hospitals.
  • Campaign against communicable diseases and special programs for treatment of non-communicable diseases will be operated. In order to prevent untimely deaths due to lack of timely treatment in remote areas, one air ambulance service equal to two districts will be operated regularly in extremely remote districts, hilly areas of far-western region and Karnali province. A national ambulance service with a centralized database will be established.
  • Community Health institutions will be evaluated on the basis of manpower, equipment, medicine, quality of service delivery, time period, management and cleanliness.
  • A special program related to maternal and newborn care and treatment services will be arranged at the local level where newborn and maternal mortality rates are high.
  • Arrangements will be made for the diagnosis and treatment of autism. As a special program, free early detection and early treatment of cervical cancer and breast cancer in women will be extended across the country.
  • Infertility and childlessness treatment services will be extended to federal hospitals in all seven provinces. Access to reproductive health services will be ensured for all. The maternity centers in all the wards of the municipality will be upgraded.
  • Necessary infrastructure, technology and manpower will be arranged to develop at least one provincial hospital into a super specialty hospital that can diagnose cancer and carry out heart surgery.
  • Medical colleges will be operated at full capacity. Assessing the manpower needed by the country in various categories of the medical field, arrangements will be made for relevant courses for the next five years.
  • The Department of Drug Administration will be converted into the Department of Food, Medicines and Health Technology. Arrangements will be made to produce 98 types of medicines within the country for basic health care services. Financial and other facilities and concessions will be provided for producing medicinal and health materials in the country to become self-reliant.
  • The production and availability of Ayurvedic medicines will be increased by restructuring Singhadurbar Vaidyakhana and Herbal Processing Centers. The services of Ayurvedic hospitals will be made effective.
  • Civil hospital and all federal hospitals will be developed as teaching hospitals. Policy will be pursued for gradually expanding civil hospitals to all seven provinces by developing them as well-equipped hospitals with specialized medical services. The Bill on Geta University will be presented in this session. The hospital will be put into operation this year.
  • The impact on social and economic life caused by the trend of unbalanced geographic distribution of the population, aging demographic situation, population growth rate below the replacement level, and increasing internal and external migration will be assessed and analyzed. The National Population Policy will be reviewed in order to make full use of the currently available demographic benefits without causing a shortage of manpower in the country in the future.
  • A health insurance program will be implemented for the treatment of prisoners.
  • Necessary process will be initiated for the establishment of an Emergency Medical Treatment Center with a view to providing emergency and specialized health care services to the injured and sick general public during major natural disasters, pandemics and large-scale disasters.
आर्थिक वर्ष २०८० 1
आर्थिक वर्ष २०८० 2
आर्थिक वर्ष २०८० 4
आर्थिक वर्ष २०८० 4
आर्थिक वर्ष २०८० 5
आर्थिक वर्ष २०८० 6

Download PDF file

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
World Hypertension Day
HypertensionPH Important DayPublic HealthPublic Health EventsPublic Health InformationPublic Health Update

World Hypertension Day 2023: Measure Your Blood Pressure Accurately, Control It, Live Longer

by Public Health Update
written by Public Health Update

Overview

The World Hypertension day is celebrated on May 17 every year. It is observed annually to raise awareness about hypertension. It was initiated by the World Hypertension League (WHL).

World Hypertension Day 2023

This year, the theme is Measure Your Blood Pressure Accurately, Control It, Live Longer.

Key facts

  • Hypertension – or elevated blood pressure – is a serious medical condition that significantly increases the risks of heart, brain, kidney and other diseases.
  • An estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries.
  • In 2015, 1 in 4 men and 1 in 5 women had hypertension.  
  • Fewer than 1 in 5 people with hypertension have the problem under control. 
  • Hypertension is a major cause of premature death worldwide.
  • One of the global targets for noncommunicable diseases is to reduce the prevalence of hypertension by 25% by 2025 (baseline 2010).
Risk factors 
  • Modifiable risk factors include unhealthy diets (excessive salt consumption, a diet high in saturated fat and trans fats, low intake of fruits and vegetables), physical inactivity, consumption of tobacco and alcohol, and being overweight or obese.
  • Non-modifiable risk factors include a family history of hypertension, age over 65 years and co-existing diseases such as diabetes or kidney disease.
Prevention is KEY! 
  • Eat healthily and reduce salt consumption
  • Eat more fruit and vegetables Limit alcohol intake
  • Don’t smoke Be physically active
  • Maintain a healthy body weight

READ MORE

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Accelerating anaemia reduction: a comprehensive framework for action
Global Health NewsInternational Plan, Policy & GuidelinesMaternal, Newborn and Child HealthPublic Health NewsWorld News

WHO calls for accelerated action to reduce anaemia

by Public Health Update
written by Public Health Update

WHO (12 May 2023)

Overview

WHO launches its first-ever comprehensive framework on reducing anaemia, calling on countries to accelerate action to halve anaemia prevalence in women of reproductive age by 2025. Progress on reducing anaemia has been slow and the world is not on track to reach the global target. Anaemia is a serious global public health problem, affecting 571 million women and 269 million young children worldwide.

In 2019, anaemia affected 40% of children between 6 months and 5 years of age, 37% of pregnant women and 30% of women 15–49 years of age. It is most prevalent in low- and middle-income countries. Anaemia increases the risk of infections and death, impairs cognitive performance, and causes extreme fatigue, poor pregnancy outcomes, loss of earnings, and poor growth and development. It is a strong indicator of overall health.

 “Most work on addressing anaemia has been focused on the prevention and treatment of iron deficiency,” says Francesco Branca, the Director of WHO’s Department of Nutrition and Food Safety. “However, anaemia is a complex condition with multiple causes – including other nutritional deficiencies, infections, inflammation, gynaecological and obstetric conditions, and inherited red blood cell disorders.” All must be addressed to effectively prevent and treat anaemia.

The new framework sets forth ways to address the direct causes, risk factors and broad social inequities that are fundamental drivers for anaemia. It describes the necessarily comprehensive approach that brings together multiple sectors and actors, and lays out key action areas to improve the coverage and uptake of interventions

Acknowledging that health remains the predominant sector for delivering many of the recommended interventions, the framework also proposes actions that other societal stakeholders can take. These include governments, civil society, academia, researchers, funding agencies, international organizations and media. Each has its particular role to perform in reducing anaemia and keeping people healthy.

The framework is launched during the International Maternal Newborn Health Conference.

Objective

This framework proposes strategic, effective and implementable actions which, by leading to the reduction of anaemia, will improve health and accelerate progress toward national and global targets.

Action areas

  • Action area 1. Analyse data on causes and risk factors
  • Action area 2. Prioritize key preventive and therapeutic interventions
  • Action area 3. Optimize service delivery across platforms and sectors
  • Action area 4. Strengthen leadership, communication and coordination, and governance at all levels
  • Action area 5. Expand research, learning and innovation

Key message

  1. Anaemia is a complex condition that must be addressed comprehensively, demanding strong leadership and collective action among multiple sectors.
  2. There are multiple causes of anaemia, including micronutrient deficiencies, inflammation, infection, uterine bleeding, and inherited red blood cell disorders.
  3. Anaemia has primarily been addressed through the nutrition lens, which is critical but not sufficient alone; rather, all causes must be addressed to effectively prevent and treat anaemia.
  4. Effective coverage of a package of interventions to address anaemia at key moments in the life course is foundational for improving health and well-being, and for preventing the irreversible consequences of anaemia.
  5. Anaemia remains a major public health problem, mainly affecting infants and children, menstruating adolescent girls and women, and pregnant and postpartum women.
  6. The burden of anaemia is unevenly distributed among countries, regions, and population groups, highlighting the role of underlying risk factors, such as poverty, gender, social and environmental inequities.

Read more: Accelerating anaemia reduction: a comprehensive framework for action (WHO)

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Bangladesh Eliminates Lymphatic Filariasis as a Public Health Problem
Global Health NewsOutbreak NewsPublic Health NewsPublic Health UpdateSuccess StoriesWorld News

Bangladesh Eliminates Lymphatic Filariasis as a Public Health Problem

by Public Health Update
written by Public Health Update

WHO 13 May 2023 News release New Delhi

In a boost to efforts to end neglected tropical diseases in WHO South-East Asia Region, Bangladesh has eliminated lymphatic filariasis, a disease that cripples and has significant social and economic impact on the affected communities. 

“Bangladesh’s achievement is commendable and follows strong political commitment, tireless efforts by health authorities, partners and the communities. It is also a result of innovative approaches and meticulous implementation of elimination strategies,” said Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia, who has been prioritizing ending neglected tropical diseases (NTDs) in the Region as one of the flagship programs. 

Lymphatic filariasis, also known as elephantiasis, occurs when filarial parasites are transmitted to humans through mosquito bites. The infection is usually acquired in childhood with painful and disfiguring visible manifestations appearing much later in life, often in the form of enlargement of body parts causing pain, severe disability, and associated stigma. 

Lymphatic filariasis was a major public health problem in Bangladesh. In 2001 the country established its national programme to eliminate lymphatic filariasis which was endemic in 19 of the 64 districts. Between 2001 and 2015, high coverage mass drug administration campaigns were rolled out in all endemic districts. 

Alongside, systematic and high-quality transmission assessment surveys were carried out by well-trained programme personnel between 2011 and 2021. 

The Regional Director also complimented Bangladesh for its morbidity management and disability prevention programme which has been regularly updating data from the endemic districts. Using this database, over 31,000 patients have been trained on self-care and provided kits to manage their disease condition and improve quality of life.

For lymphatic filariasis elimination, WHO strategy is based on two key components – first, stopping spread of infection through large-scale annual treatment of entire populations at risk in an area or region where transmission is present; and second, alleviating the suffering caused by lymphatic filariasis through increased disease management and disability prevention measures. 

As part of the validation process, Bangladesh submitted a dossier to WHO which was reviewed by a Regional Dossier Review Group. After examining the dossier, the Regional Dossier Review Group recommended Bangladesh for validation of elimination of lymphatic filariasis as a public health problem. 

“Strong partnership, several innovative operational research projects in surveillance methodologies and well-trained programme personnel have been key to the country’s success and will continue to be critical for the country to sustain its status of lymphatic filariasis elimination,” Dr Khetrapal Singh said. 

Bangladesh’s national strategic plan 2018-2025 focuses on post-validation surveillance strategy and response measures to prevent recrudescence of infection and progress towards elimination of transmission. 

Bangladesh is the fourth country in WHO South-East Asia Region to eliminate lymphatic filariasis as a public health problem after Maldives, Sri Lanka and Thailand.   

In 2014, Dr Khetrapal Singh identified ending neglected tropical diseases as one of her flagship priorities. 

Besides lymphatic filariasis, there has been successes against other neglected tropical diseases. India has been certified for ending yaws and Nepal and Myanmar have eliminated trachoma as a public health problem. 

“Neglected tropical diseases affect the marginalized and the vulnerable communities, aggravating their sufferings manifold. With low-cost and highly effective drugs and treatments we must end NTDs. WHO remains committed to support efforts to eliminate these diseases to achieve a healthier, more equitable and sustainable future for everyone, everywhere,” the Regional Director said. 

WHO 13 May 2023 News release New Delhi

Related

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Call for Abstracts! 64th ITM Colloquium 2023
AbstractsCall for Proposal, EOI & RFPConferencePublic Health OpportunitiesPublic Health Opportunity

Call for Abstracts! 64th ITM Colloquium 2023

by Public Health Update
written by Public Health Update

Understanding the global landscape of disease burden in the context of climate change

The Institute of Tropical Medicine in Antwerp and the Nepal Health Research Council would like to invite you to the 64th ITM Colloquium, held in Kathmandu, Nepal from 21 to 23 November. This will be a great opportunity to share knowledge, expertise and perspectives to discuss the global landscape of disease burden in the context of climate change.

The conference programme includes lectures from outstanding international experts on climate change impact research. The colloquium contains six sessions:

  1. Climate Change and Planetary Health
  2. Uncovering the Complex Relationship Between Infectious Diseases and Climate Change
  3. Climate Change and Mental Health
  4. Addressing Non-communicable Diseases and Climate Change
  5. Climate Change, Child Health and Sexual and Reproductive Health
  6. Global and National Response to address Health Risks of Climate Change

SUBMISSION GUIDELINES

  • A reference template can be downloaded here.
  • The main text of the abstract should be maximum 250 words.
  • All abstracts must be submitted and presented in English.
  • Authors and contributors are encouraged to have their texts proofread by external reviewers.
  • The submission will be confirmed by an automatic e-mail notification.
  • All submitted abstracts are subjected to a peer review process. After the evaluation, corresponding authors will receive feedback until 31 July 2023.
  • The Scientific Committee may change the requested presentation type from oral to poster or from poster to an oral presentation following consultation with and approval by the authors.
  • The accepted abstracts require at least one of the authors to have pre-registered for the event in order to ensure that the presenters are committed to attending the conference and presenting their work.
  • Along with your abstract, you are required to submit a CV, and a short motivation letter.
  • In case you find any difficulty in submitting your abstract electronically, please contact colloquium@itg.be.

Call for abstracts – Deadline 30 June 2023

The Scientific Committee now welcomes the submission of abstracts for original contributions to the topic ‘Understanding the global landscape of disease burden in the context of climate change’.

Authors may submit abstracts relevant to the sessions either as an oral or as a poster contribution. The abstracts submitted will be assessed, peer reviewed and grouped by topic. 
You can find all the instructions to submit your abstract on the colloquium website.

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
MPOX is No longer a Public Health Emergency
Global Health NewsOutbreak NewsPublic Health NewsPublic Health UpdateWorld News

MPOX is No longer a Public Health Emergency

by Public Health Update
written by Public Health Update

The World Health Organization (WHO) says Mpox (monkeypox), an infectious disease caused by the monkeypox virus is no longer a public health emergency of International Concern. It was declared public health emergency of international concern over the multi-country outbreak of mpox in July 2022.

The Fifth Meeting of the International Health Regulations (2005) (IHR) Emergency Committee on the Multi-Country Outbreak of monkeypox (mpox) recommended to WHO DG that the outbreak no longer represents a public health emergency of international concern.

The Committee acknowledged remaining uncertainties about the disease, regarding modes of transmission in some countries, poor quality of some reported data, and continued lack of effective countermeasures in the African countries, where mpox occurs regularly.

The Committee considered, however, that these are long-term challenges that would be better addressed through sustained efforts in a transition towards a long-term strategy to manage the public health risks posed by mpox, rather than the emergency measures inherent to a public health emergency of international concern (PHEIC).

More Info: WHO

Related readings

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
The Sixth GACD Implementation Science School 2023
Implementation ResearchInternational Jobs & OpportunitiesOnline & Distance LearningOnline CoursesPublic Health OpportunitiesPublic Health Opportunity

The Sixth GACD Implementation Science School 2023

by Public Health Update
written by Public Health Update

Global Alliance for Chronic Diseases (GACD) Implementation Science School is an intensive programme for early-career researchers, facilitated by some of the field’s most prominent global experts. Through lectures, small group sessions, facilitated group work, and panel discussions, trainees learn how to study and implement research findings into policy and practice, select and apply theories, models, and frameworks, and create a professional network for future collaborations.

The aims of the School include:

  • To introduce early- and mid-career researchers to the field of implementation science.
  • To facilitate collaboration and networking.
  • To explore examples of implementation research and the process of moving research findings into policy and practice.

The School is intended for early-career researchers, particularly those based in institutions in low- and middle-income countries who are already participating in, or intend to actively participate in, an implementation research activity related to non-communicable diseases. Up to forty trainees will be selected for the School.

Overview of live sessions

Below is an overview of the School dates for 2023. The School’s training materials and live interactions are accessible entirely online. Trainees are expected to attend all plenary sessions and all relevant group sessions.

All times are listed in Universal Coordinated Time (UTC) on the dates specified. You are strongly encouraged to double check conversion to your local time.

  • Trainee orientation session
    • Plenary session on 14 September 2023 at 11:00-12:00 UTC
  • Session 1: Introduction to implementation science
    • Plenary session on 18 September 2023 at 11:30-13:00 UTC
    • Group session A on 18 September 2023 at 14:00 UTC (up to two hours)
    • Group session B on 19 September 2023 at 06:30 UTC (up to two hours)
  • Session 2: The nuts and bolts of implementation science
    • Plenary session on 20 September 2023 at 11:30-13:00 UTC
    • Group session A on 20 September 2023 at 14:00 UTC (up to two hours)
    • Group session B on 21 September 2023 at 06:30 UTC (up to two hours)
  • Session 3: Stakeholder engagement
    • Plenary session on 25 September 2023 at 11:30-13:00 UTC
    • Group session A on 25 September 2023 at 14:00 UTC (up to two hours)
    • Group session B on 26 September 2023 at 06:30 UTC (up to two hours)
  • Session 4: A population perspective for implementation research
    • Plenary session on 27 September 2023 at 11:30-13:00 UTC
    • Group session A on 27 September 2023 at 14:00 UTC (up to two hours)
    • Group session B on 28 September 2023 at 06:30 UTC (up to two hours)
  • Session 5: Research funding, capacity strengthening, and career development
    • Plenary session on 2 October 2023 at 11:30-13:00 UTC
    • Group session A on 2 October 2023 at 14:00 UTC (up to two hours)
    • Group session B on 3 October 2023 at 06:30 UTC (up to two hours)
  • Session 6: Team presentations and reflections
    • Plenary session on 4 October 2023 at 11:15-13:15 UTC

Access to learning materials

Selected trainees are asked to watch all the lecture recording under the Fundamentals Programme on the GACD e-Hub in advance of the School start date. All materials forming the core learning of the School are open access.

Eligibility and applications

Eligible applicants include people who meet one of the following criteria:

  • Have completed or are undertaking postgraduate coursework or research related to health science or public health (or a related field).
  • Have recently completed a PhD relevant to implementation science.
  • Are other relevant graduates with up to 5 years research experience.

Preference will be given to:

  • Applicants whose research is connected with a GACD project or are focused on non-communicable diseases.
  • Applicants from low- and middle-income countries or members of Indigenous communities.
  • Early- and mid-career applicants undertaking their research within low- and middle-income countries or with Indigenous populations in high-income countries.

To ensure international diversity, trainees from any one institution may be limited. Attendees from previous GACD Implementation Science Schools will not be eligible for this event.

Applicants will be asked to submit the following information during the application process for consideration by the selection committee:

  • A personal statement on why you are a good candidate for the School.
  • Your two main objectives in attending the School.
  • A structured abstract of an implementation science project you are working on or would like to work on in the future, detailing:
    • Project title, the implementation gap, the extent of the issue in your local context, barriers and enablers, implementation strategies, and research methods.
    • These may be details you are considering, planning to use, or currently using in your project.
    • The project can be hypothetical if you are not currently working on an implementation research study.
  • Your curriculum vitae (CV) / resume.
  • Letter of support from your mentor or supervisor.
  • A photograph of yourself .

GACD wish to ensure a diversity in the attendees across geography, institution, gender, and pending exceptional circumstances, only one applicant per institute or centre will be accepted.

Applications for GACD’s Sixth Implementation Science School 2023 are now open and you can access the application form here. Applications will close at 08:00 BST on Monday 19 June 2023.

OFFICIAL INFO

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
The 2023 Edition of the Introductory Course for Standard Practice (GxP)
CoursesInternational Jobs & OpportunitiesPublic Health OpportunitiesPublic Health Opportunity

The 2023 Edition of the Introductory Course for Standard Practice (GxP)

by Public Health Update
written by Public Health Update

The Global Training Hub for Biomanufacturing (GTH-B) is now accepting applications for the 2023 edition of the Introductory Course for Standard Practice (GxP), focusing on Good Clinical, Manufacturing and Laboratory Practice (GCP, GMP, GLP) and the basics of biosafety in the development and manufacturing of vaccines and other bioproducts.

When: October 30–November 17, 2023 (3 weeks)
Where: Republic of Korea

We strongly encourage applications from technicians, engineers, and managers with up to 6 years of experience working in bioproduction (vaccines, therapeutics, monoclonal antibodies, etc.) at a facility based in a low- or middle-income country. The course will run for 15 working days covering 120 hours of coursework, excursions, and examination, and qualifying trainees will receive a certificate of completion. 

Course Information (Offline, South Korea)

  • Course Content: Good clinical, manufacturing, laboratory practice (GCP, GMP, GLP) and biosafety for adherence to international standard of quality in vaccine and biomedical product development.
  • Course Duration: 15 working days, (3 calendar weeks)
  • Faculty: Area-specific experts
  • Hours of Training: 120 hours including hands-on training, excursion, and tests
  • Excursion Sites: Hospital clinical centers, biomedical product development and research sites, manufacturing sites
  • Target Trainees: 150 trainees from South Korea and Low- and Middle-Income Countries (LMICs).
  • Trainee Qualification: Technician, engineer, scientist, and manager with up to 6 years of experience in biomanufacturing, or related experience
  • Certificate of completion: Certificates will be issued if trainee participation exceeds 90% of the whole training, which will be assessed through exams.

Applications are due Friday, June 30, 2023 at 18:00 (Korea Standard Time)

Applicants are required to

  • Have an educational background in a life science field and hold a position as a technician, engineer, scientist, or manager with up to 6 years of experience in biomanufacturing (or related experience).
  • Be a citizen or resident of a low- or middle-income country, employed by a company registered as a legal entity in a LMIC.
  • Have at least an intermediate level of spoken and written English language.

Fees:

The entire course is free of charge to all participants. Accommodation and breakfast will be provided during the entirety of the course including weekends. Lunch and dinner will only be provided on session days (excluding weekends). 

Travel costs to/from Seoul, Republic of Korea will not be provided. Applicants must separately secure airfare at their own expense.

READ MORE AND APPLY

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
WHO declares end to COVID 19 as a Public Health Emergency of International Concern
Global Health NewsNational Health NewsOutbreak NewsPublic HealthPublic Health NewsPublic Health UpdateWorld News

WHO declares end to COVID 19 as a Public Health Emergency of International Concern

by Public Health Update
written by Public Health Update

The World Health Organization (WHO) declared an end to COVID-19 as a Public Health Emergency of International Concern (PHEIC) as per the advice offered by the fifteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic.  WHO first issued the PHEIC declaration in January 2020.

Statement on the fifteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

WHO (5 May 2023)

The WHO Director-General has the pleasure of transmitting the Report of the fifteenth meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the coronavirus 2019 disease (COVID-19) pandemic, held on Thursday 4 May 2023, from 12:00 to 17:00 CET.

During the deliberative session, the Committee members highlighted the decreasing trend in COVID-19  deaths, the decline in COVID-19 related hospitalizations and intensive care unit admissions, and the high levels of population immunity to SARS-CoV-2. The Committee’s position has been evolving over the last several months. While acknowledging the remaining uncertainties posted by potential evolution of SARS-CoV-2, they advised that it is time to transition to long-term management of the COVID-19 pandemic.

The WHO Director-General concurs with the advice offered by the Committee regarding the ongoing COVID-19 pandemic. He determines that COVID-19 is now an established and ongoing health issue which no longer constitutes a public health emergency of international concern (PHEIC).

The WHO Director-General considered the advice provided by the Committee regarding the proposed Temporary Recommendations and issued them as per the below statement. The WHO Director-General will convene an IHR Review Committee to advise on Standing Recommendations for the long-term management of the SARS-CoV-2 pandemic, taking into account the 2023-2025 COVID-19 Strategic Preparedness and Response Plan. During this transition, States Parties are advised to continue following the issued Temporary Recommendations. The Director-General expressed his sincere gratitude to the Chair, the Members, and the Advisors of the Committee for their engagement and advice during the last three years.

WHO (5 May 2023)

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Newer Posts
Older Posts
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023